The use of bioisosteric groups in lead optimization

被引：58

作者：

Chen, XQ

Wang, WB

机构：

[1] Tularik Inc, San Francisco, CA 94080 USA

[2] Chiron Corp, Emeryville, CA 94608 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38 | 2003年 / 38卷

关键词：

D O I：

10.1016/S0065-7743(03)38033-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：333 / 346

页数：14

共 72 条

[1] Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)pyridazinebutanoic acid (FK838):: A novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity [J].

Akahane, A ;

Katayama, H ;

Mitsunaga, T ;

Kato, T ;

Kinoshita, T ;

Kita, Y ;

Kusunoki, T ;

Terai, T ;

Yoshida, K ;

Shiokawa, Y .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :779-783

[2]

[Anonymous], 1983, CHEM BIOCH AMINO ACI

[3] Thienopyridines: Nitric oxide synthase inhibitors with potent in vivo activity [J].

Beaton, H ;

Boughton-Smith, N ;

Hamley, P ;

Ghelani, A ;

Nicholls, DJ ;

Tinker, AC ;

Wallace, AV .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (08) :1027-1030

[4] 3-aminopyrrolidinone farnesyltransferase inhibitors: Design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency [J].

Bell, IM ;

Gallicchio, SN ;

Abrams, M ;

Beese, LS ;

Beshore, DC ;

Bhimnathwala, H ;

Bogusky, MJ ;

Buser, CA ;

Culberson, JC ;

Davide, J ;

Ellis-Hutchings, M ;

Fernandes, C ;

Gibbs, JB ;

Graham, SL ;

Hamilton, KA ;

Hartman, GD ;

Heimbrook, DC ;

Homnick, CF ;

Huber, HE ;

Huff, JR ;

Kassahun, K ;

Koblan, KS ;

Kohl, NE ;

Lobell, RB ;

Lynch, JJ ;

Robinson, R ;

Rodrigues, AD ;

Taylor, JS ;

Walsh, ES ;

Williams, TM ;

Zartman, CB .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2388-2409

[5]

BENHAMOU Y, 2002, 53 ANN M AM ASS STUD, P563

[6]

BOYD RE, 1997, Patent No. 5621113

[7]

BOYD RE, 1998, Patent No. 5750720

[8] Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles [J].

Breslin, HJ ;

Miskowski, TA ;

Kukla, MJ ;

Leister, WH ;

De Winter, HL ;

Gauthier, DA ;

Somers, MVF ;

Peeters, DCG ;

Roevens, PWM .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (24) :5303-5310

[9] The chemistry of pseudomonic acid .15. Synthesis and antibacterial activity of a series of 5-alkyl, 5-alkenyl, and 5-heterosubstituted oxazoles [J].

Brown, P ;

Davies, DT ;

OHanlon, PJ ;

Wilson, JM .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :446-457

[10] Designing non-peptide peptidomimetics in the 21st century: Inhibitors targeting conformational ensembles [J].

Bursavich, MG ;

Rich, DH .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) :541-558

← 1 2 3 4 5 6 7 8 →